Tim Bettington
Corporate Officer/Principal at ELANCO ANIMAL HEALTH INCORPORATED
Net worth: 2 M $ as of 2024-03-30
Profile
Tim Bettington is currently the Executive Vice President-Corporate Strategy at Elanco Animal Health, Inc. He previously worked as the Executive Vice President & President-US Operations at Zoetis, Inc. and as the Head-Commercial Operations at Boehringer Ingelheim Animal Health USA, Inc. from 2017 to 2019.
He has an undergraduate degree from the University of Western Sydney and a graduate degree from Macquarie Graduate School of Management Pty Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-02 | 106,387 ( 0.02% ) | 2 M $ | 2024-03-30 |
Tim Bettington active positions
| Companies | Position | Start |
|---|---|---|
| ELANCO ANIMAL HEALTH INCORPORATED | Corporate Officer/Principal | 2023-03-19 |
Former positions of Tim Bettington
| Companies | Position | End |
|---|---|---|
Boehringer Ingelheim Animal Health USA, Inc.
 Boehringer Ingelheim Animal Health USA, Inc. BiotechnologyHealth Technology Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA. | Corporate Officer/Principal | 2018-12-31 |
| ZOETIS INC. | Corporate Officer/Principal | - |
Training of Tim Bettington
| University of Western Sydney | Undergraduate Degree |
| Macquarie Graduate School of Management Pty Ltd. | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ZOETIS INC. | Health Technology |
| ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
| Private companies | 1 |
|---|---|
Boehringer Ingelheim Animal Health USA, Inc.
Boehringer Ingelheim Animal Health USA, Inc. BiotechnologyHealth Technology Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA. | Health Technology |
- Stock Market
- Insiders
- Tim Bettington
